Deptartment of Neurology, CBF, Charité-University Medicine Berlin, Hindenburdamm 30, 12203 Berlin, Germany.
J Neural Transm (Vienna). 2012 Mar;119(3):369-72. doi: 10.1007/s00702-011-0689-3. Epub 2011 Jul 24.
Levodopa/Carbidopa intestinal gel infusion (LCIG) for Parkinson's disease is under debate to provoke polyneuropathy (PNP). In our cohort of 20 thus treated patients, two developed debilitating axonal PNP with deficient pyridoxin and folate levels, and marginal cobalamin. Homocysteine was highly elevated. The neuropathies responded to vitamin replacement. We assume that LCIG can provoke PNP most likely of malnutritional origin. To avoid this side effect, the assessment of predisposing factors before treatment as well as neurophysiological and laboratory screenings appear necessary.
左旋多巴/卡比多巴肠内凝胶输注(LCIG)治疗帕金森病是否会引发多发性神经病(PNP)存在争议。在我们治疗的 20 名患者队列中,有 2 名患者出现了进行性轴索性 PNP,伴有吡哆醇和叶酸水平不足以及边缘钴胺素。同型半胱氨酸水平显著升高。神经病变对维生素替代治疗有反应。我们假设 LCIG 可能最容易引发由营养不良引起的 PNP。为了避免这种副作用,在治疗前评估易患因素以及进行神经生理学和实验室筛查似乎是必要的。